Related Experiment Video
Updated: Feb 11, 2026

Production and Detection of Reactive Oxygen Species ROS in Cancers
Published on: November 21, 2011
Melatonin Inhibits Reactive Oxygen Species-Driven Proliferation, Epithelial-Mesenchymal Transition, and Vasculogenic
Rui Liu1,2,3, Hui-Li Wang4, Man-Jing Deng1
1Department of Stomatology, Daping Hospital and Research Institute of Surgery, Third Military Medical University, Chongqing 400042, China.
Abstract:
Globally, oral cancer is the most common type of head and neck cancers. Melatonin elicits inhibitory effects on oral cancer; however, the biological function of melatonin and underlying mechanisms remain largely unknown. In this study, we found that melatonin impaired the proliferation and apoptosis resistance of oral cancer cells by inactivating ROS-dependent Akt signaling, involving in downregulation of cyclin D1, PCNA, and Bcl-2 and upregulation of Bax. Melatonin inhibited the migration and invasion of oral cancer cells by repressing ROS-activated Akt signaling, implicating with the reduction of Snail and Vimentin and the enhancement of E-cadherin. Moreover, melatonin hampered vasculogenic mimicry of oral cancer cells through blockage of ROS-activated extracellular-regulated protein kinases (ERKs) and Akt pathways involving the hypoxia-inducible factor 1α. Consistently, melatonin retarded tumorigenesis of oral cancer in vivo. Overall, these findings indicated that melatonin exerts antisurvival, antimotility, and antiangiogenesis effects on oral cancer partly by suppressing ROS-reliant Akt or ERK signaling.
Insights
Melatonin inhibits oral cancer growth by reducing cell survival, migration, and blood vessel formation. These effects are mediated by blocking reactive oxygen species (ROS)-dependent Akt and ERK signaling pathways.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Oral cancer is a prevalent head and neck malignancy.
- Melatonin shows potential in inhibiting oral cancer, but its mechanisms are unclear.
Purpose of the Study:
- To investigate the biological functions and mechanisms of melatonin in oral cancer.
- To elucidate how melatonin affects oral cancer cell proliferation, apoptosis, migration, invasion, and vasculogenic mimicry.
Main Methods:
- In vitro studies on oral cancer cells to assess proliferation, apoptosis, migration, and invasion.
- Analysis of signaling pathways including ROS-dependent Akt and ERK.
- In vivo studies to evaluate melatonin's effect on tumor growth.
Main Results:
- Melatonin impaired oral cancer cell proliferation and apoptosis resistance via ROS-dependent Akt inactivation.
- Melatonin inhibited oral cancer cell migration and invasion by repressing ROS-activated Akt signaling.
- Melatonin hampered vasculogenic mimicry by blocking ROS-activated ERK and Akt pathways.
- Melatonin retarded oral cancer tumorigenesis in vivo.
Conclusions:
- Melatonin exhibits antisurvival, antimotility, and antiangiogenesis effects on oral cancer.
- These effects are partly mediated by suppressing ROS-reliant Akt or ERK signaling pathways.
Related Concept Videos
Nonconscious Mimicry
Cooperative Allosteric Transitions
Phase Transitions
What is a Species?
Feedback Inhibition
Properties of Transition Metals

